Pharma IQ Members

Philip
Rothaus

Although there has been relatively more focus on CROs performing clinical trials in emerging markets, CMO activity is continually increasing in these regions with a bulk of the global API supply now being manufactured in China and India. Legitimate concerns have been raised about the globalization of biomedical and pharmaceutical manufacturing...Full Article »